ENVALITH
日本酸素ホールディングス株式会社 logo

NIPPON SANSOHOLDINGS CORPORATION

4091Prime MarketChemicals

日本酸素ホールディングス株式会社 logo
NIPPON SANSOHOLDINGS CORPORATION4091

Business

Nippon Sanso Holdings is a pure holding company whose core business is the manufacture and sale of industrial gases (oxygen, nitrogen, argon, etc.), medical gases, and specialty gases (including electronic materials gases). In Japan, it operates the country's largest industrial gas business through Taiyo Nippon Sanso (renamed Nippon Sanso from April 2026); in the United States through Matheson Tri-Gas (renamed Nippon Sanso Matheson); in Europe through the Nippon Gases Euro-Holding group; and in Asia & Oceania through subsidiaries including Australia's Coregas. Its main customers span a wide range of industries, including steel, chemicals, semiconductors, medical, and food. The company also operates a B-to-C business selling Stainless Steel Vacuum Bottles and other products under the Thermos brand. Revenue for FY2026 (ending March 2026) was ¥1,359,611 million.

Business Model

Industrial gases are supplied stably through on-site plants adjacent to customer factories and long-term supply contracts, forming a structural stock-type revenue model with high switching costs. Cost increases are passed through to selling prices via price management, maintaining profitability. In addition, the company expands its regional and customer base through active M&A in Europe, the United States, and Asia, pursuing economies of scale and synergies. It also invests ¥5,741 million in R&D expenses to promote higher value-added products through the development of specialty gases for advanced semiconductors and new materials.

Company Strengths

Revenue is diversified across four segments: Japan, the United States, Europe, and Asia & Oceania. In FY2026 (ending March 2026), segment revenue was ¥406,296 million in Japan, ¥360,557 million in the United States, ¥350,978 million in Europe, and ¥208,452 million in Asia & Oceania, reflecting advancing geographic diversification that reduces dependence on any single region or currency.

Even amid cost increases, the company has continuously implemented price management for carbon dioxide gas, packaged gas, electronic materials gases, and other products. In FY2026 (ending March 2026), despite an overall decline in shipment volumes year on year, revenue grew 3.9% and core operating profit grew 7.4%, achieving simultaneous revenue and profit growth—demonstrating strong pricing power in practice.

The company completed multiple strategic acquisitions in the most recent fiscal year alone, including the acquisition of Coregas Group in Australia (acquisition consideration of ¥71,521 million), the acquisition of ETH in Spain, and the acquisition of Polaris in Italy. Since acquiring its European business in 2014, the company has continuously executed global M&A, expanding revenue from ¥957,169 million in FY2022 (ended March 2022) to ¥1,359,611 million in FY2026 (ending March 2026).

ENVALITH's Perspective

In FY2026 (ending March 2026), despite a year-on-year decline in shipment volume across the group as a whole, the company achieved substantial profit growth, with core operating profit up 7.4% to ¥203,084 million and profit attributable to owners of parent up 25.4% to ¥123,891 million. Meanwhile, core operating profit in the U.S. segment declined 11.5% year on year to ¥52,914 million, reflecting the emerging impact of rising costs and lower shipment volumes. The recovery of U.S. profitability holds the key to overall profit growth.

A new medium-term management plan covering FY2027 (ending March 2027) through FY2030 (ending March 2030) has been formulated, but the earnings report only presents the direction of three priority strategies, with no specific numerical targets disclosed. The FY2027 (ending March 2027) forecast calls for revenue of ¥1,380,000 million (up 1.5% year on year) and core operating profit of ¥208,000 million (up 2.4% year on year), giving a conservative impression. This appears to reflect cautious assumptions given uncertainties such as U.S. tariff policy, but disclosure of quantitative targets under the mid-term plan will be a key factor shaping investor assessment.

On April 28, 2026, the company entered into a sale and purchase agreement for the head office land (Shinagawa-ku, Tokyo), with an estimated gain on sale of ¥12,421 million (delivery scheduled for May 28, 2026). Meanwhile, an impairment loss of ¥1,865 million (estimated) on the building associated with the head office relocation is also expected to be recorded. The net effect is expected to boost net profit by approximately ¥10,556 million in FY2027 (ending March 2027), and the relationship between this and the earnings forecast for that period (operating profit of ¥215,000 million) warrants careful examination.

Growth Strategy

Growth driven by three pillars: strengthening industrial gas profitability, expanding the electronics business, and regional reinforcement through M&A

Continued to pass through cost increases to sales prices in each region and implemented productivity improvement programs. In FY2026 (ending March 2026), the company achieved a core operating margin of 14.9% even as group-wide shipment volumes declined. In FY2027 (ending March 2027), the company aims to continue the same measures and achieve core operating profit of ¥208,000 million (up 2.4% year on year).

In Japan, progress was confirmed on medium- to large-scale electronics-related construction projects, while in Asia & Oceania, a recovery in shipment volumes of electronic materials gases was confirmed. This is positioned as one of the key strategies of the medium-term management plan "Next Innovation 2030," and the company will continue to focus investment on the Asia region. A recovery in the semiconductor market is providing a tailwind as an external factor.

In July 2025, the company acquired Coregas Group of Australia (acquisition cost of ¥71,521 million), significantly expanding its industrial gas and Welding-Related Business in Oceania. In March 2026, it acquired ETH of Spain (acquisition cost of ¥22,432 million), enhancing its presence in the European home healthcare field. The Asia & Oceania segment achieved high growth, with revenue up 18.1% year on year to ¥208,452 million and core operating profit up 31.2% year on year to ¥19,746 million.

As the third key strategy of the medium-term management plan "Next Innovation 2030," the company has set forth the creation of new carbon-neutrality-related businesses such as hydrogen and CO2 capture. Specific numerical targets have not yet been disclosed, but the company aims to adapt to environmental changes in industry and society through an innovation mindset and strengthened technological capabilities.

Last updated: July 19, 2026